| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $59.6M | +18.7% |
| Cost of Revenue | $29.8M | +19.5% |
| Gross Profit | $29.9M | +17.9% |
| R&D Expense | $25.5M | +16.4% |
| SG&A Expense | $53.6M | +16.2% |
| Operating Income | -$76.7M | -79.4% |
| Pre-tax Income | -$72.5M | -98.0% |
| Income Tax | -$282K | -33.6% |
| Net Income | -$72.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.0M | -63.6% |
| Short-term Investments | $25.6M | +3.8% |
| Accounts Receivable | $12.6M | +40.5% |
| Inventory | $16.2M | +8.3% |
| Current Assets | $103.1M | -40.7% |
| Total Assets | $159.5M | -21.4% |
| Current Liabilities | $25.1M | +11.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.2M | -20.7% |
| Capital Expenditures | $602K | -70.6% |
| Investing Cash Flow | -$46.3M | -75.5% |
| Financing Cash Flow | -$376K | +97.6% |
| Free Cash Flow | -$30.8M | -13.8% |
| -98.4% |
| EPS (Basic) | -$2.12 | -87.6% |
| EPS (Diluted) | -$2.12 | -87.6% |
| Total Liabilities |
| $44.9M |
| +19.7% |
| Stockholders' Equity | $114.6M | -30.8% |